Repare Therapeutics Inc. Earnings Per Share, Basic and Diluted
Repare Therapeutics Inc. reported Earnings Per Share, Basic and Diluted of -$0.83 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- Repare Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.83.
- Repare Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.70.
- Repare Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.83.
- Repare Therapeutics Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.71.
- Repare Therapeutics Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.83.
- Repare Therapeutics Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.66.
- Repare Therapeutics Inc. earnings per share, basic and diluted for fiscal 2019 was -$17.81.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.83 10-Q · filed 2022-05-05 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$2.36 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$3.08 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-12-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.53 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.24 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$2.83 10-K · filed 2022-03-01 |
| 2021-09-30 | -$0.83 10-Q · filed 2021-11-10 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$2.12 10-Q · filed 2021-11-10 | -$2.54 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-06-30 | -$0.71 10-Q · filed 2021-08-12 | -$1.29 10-Q · filed 2021-08-12 | -$1.71 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$2.08 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-03-31 | -$0.58 10-Q · filed 2022-05-05 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$1.37 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$2.16 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$2.66 10-K · filed 2022-03-01 |
| 2020-09-30 | -$0.37 10-Q · filed 2021-11-10 | -$1.23 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.63 10-Q · filed 2021-11-10 | -$4.16 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-06-30 | -$2.45 10-Q · filed 2021-08-12 | -$7.56 10-Q · filed 2021-08-12 | -$12.29 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$16.99 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2020-03-31 | -$7.71 10-Q · filed 2021-05-13 | -$13.24 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$18.30 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$22.50 derived: net income ÷ weighted average shares · filed 2022-03-01 |
| 2019-12-31 | -$5.45 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$10.48 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$14.64 derived: net income ÷ weighted average shares · filed 2022-03-01 | -$17.81 10-K · filed 2022-03-01 |
| 2019-09-30 | -$5.03 10-Q · filed 2020-11-12 | -$9.19 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$12.36 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$4.16 10-Q · filed 2020-08-13 | -$7.33 10-Q · filed 2020-08-13 |